Ipsen S.A. - Strategy, SWOT and Corporate Finance Report
Summary
Ipsen S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ipsen S.A. (Ipsen or 'the company') is a pharmaceutical company that offers drugs on targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. Ipsen provides products for neurodegenerative pathologies, and rheumatology diseases and gastrointestinal disorders. It distributes its drugs to various public hospitals. Ipsen sells its products under Adrovance, Dysport, Decapeptyl, Adenuric, NutropinAq, Smecta, Somatuline and Tanakan brand names. Ipsen has business operations in North America, Asia and Europe. The company is headquartered in Boulogne-Billancourt, Paris, France.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook